Zantac’s maker kept quiet about cancer risks for 40 years
41–50 of 134 posts
Re: Zantac’s maker kept quiet about cancer risks for 40 years
#42Re: Zantac’s maker kept quiet about cancer risks for 40 years
#43Re: Zantac’s maker kept quiet about cancer risks for 40 years
#44Earlier quoted context omitted.
My understanding is that the carcinogen (NDMA) builds up over time even with storage at recommended temperatures, though increased temperature makes it build up much faster. That's what the FDA said when they pulled it from the market. How old your ranitidine would have to be to have too-high NDMA level without higher heat, I haven't seen any specifics around that. I imagine they could have instead instituted limits…
Even something as simple as telling people to store the bottle in the refrigerator...
Re: Zantac’s maker kept quiet about cancer risks for 40 years
#45Re: Zantac’s maker kept quiet about cancer risks for 40 years
#46Earlier quoted context omitted.
> "What's my recourse?" A lawsuit, like the thousands mentioned in the article.
How would I have known to file a lawsuit about something when I had no knowledge of the situation for years?
Re: Zantac’s maker kept quiet about cancer risks for 40 years
#47Earlier quoted context omitted.
> "What's my recourse?" A lawsuit, like the thousands mentioned in the article.
How would I have known to file a lawsuit about something when I had no knowledge of the situation for years?
There's nothing unique or novel about this situation. Is it surprisingly that it happened or just surprising that it happened to you? This is what we do son, this is what american is for. This is the system working as intended.
Re: Zantac’s maker kept quiet about cancer risks for 40 years
#48> Intense public scrutiny on Zantac started in 2019, when an online pharmacy found high levels of a likely carcinogen in the drug and its generics. And the linked article says: > Valisure discovered the link of Zantac and its generics to the carcinogen NDMA during its routine testing of every batch of every medication, and first notified the FDA of its initial findings in June of 2019. On September 13th, Valisure fil…
This means that they have to do some inbound quality control to ensure that what they believe they are selling really is what they are selling.
Re: Zantac’s maker kept quiet about cancer risks for 40 years
#49> Intense public scrutiny on Zantac started in 2019, when an online pharmacy found high levels of a likely carcinogen in the drug and its generics. And the linked article says: > Valisure discovered the link of Zantac and its generics to the carcinogen NDMA during its routine testing of every batch of every medication, and first notified the FDA of its initial findings in June of 2019. On September 13th, Valisure fil…
I suspect it's not that they go out of their way to do extra testing, it's that they don't necessarily trust suppliers but willing to eat the cost of testing + risk of bad inputs because they still net ahead compared to more reputable but expensive suppliers.
Re: Zantac’s maker kept quiet about cancer risks for 40 years
#50Earlier quoted context omitted.
You realize GSK is a UK pharma company... right?
They do business in the US right? There is an expansive extradition treaty right?
https://corporateeurope.org/en/2021/05/big-pharmas-lobbying-...